Belinta 60mg Tablet
Product introduction
Belinta 60mg Tablet is also used to treat people with a recent heart attack or severe heart-related chest pain (unstable angina) who have undergone stenting of the heart. It helps to prevent serious heart-related problems like having another heart attack, stroke, or formation of blood clots in stents in such people.
Your doctor will also prescribe aspirin, another antiplatelet medicine, along with this medicine. Belinta 60mg Tablet may be taken with or without food and should be taken regularly at the same time each day. It is important to keep taking it even if you feel well. If you stop taking this medicine, it may increase your chances of having another heart attack or stroke.
The most common side effects of this medicine are dyspnea (breathlessness) and bleeding. If you cut or injure yourself, it may take longer than usual for the bleeding to stop. Such episodes of bleeding are usually mild and resolve on their own. Mild breathlessness caused by this medicine usually resolves on its own with continued treatment. Let your doctor know if bleeding persists or if the breathlessness worsens or does not go away.
Belinta 60mg Tablet is not suitable for some people. Do not take it if you are bleeding from anywhere in the body, such as a stomach ulcer or bleeding within the brain. It is also not recommended for people with liver diseases. Before using the medicine, inform your doctor of any such problems.
Uses of Belinta Tablet
- Heart attack
- Prevention of heart attack and stroke
- Unstable angina
Benefits of Belinta Tablet
In Prevention of heart attack and stroke
Side effects of Belinta Tablet
Common side effects of Belinta
- Bleeding
- Breathlessness
How to use Belinta Tablet
How Belinta Tablet works
Safety advice
Dizziness, confusion, vertigo, and syncope have been reported in some patients. If you experience such symptoms, be cautious while driving or using machines.
Limited information is available on the use of Belinta 60mg Tablet in renal dialysis patients.
Use of Belinta 60mg Tablet is not recommended in patients with severe liver disease.
What if you forget to take Belinta Tablet?
All substitutes
Quick tips
- For best results, take it at the same time every day.
- Belinta 60mg Tablet increases your risk of bleeding. Be careful while shaving, using sharp objects, or cutting fingernails or toenails.
- Do not discontinue using the medicine without consulting your doctor, as this may increase your chances of having another heart attack or stroke.
- If you are scheduled to undergo surgery or dental treatment, you may be asked to temporarily stop taking Belinta 60mg Tablet.
- You may experience shortness of breath in the initial weeks of therapy. Notify your doctor if it becomes worse or persists for long.
Fact Box
Interaction with drugs
Patient concerns
FAQs
Is Belinta 60mg Tablet an anticoagulant?
Can I drink alcohol with Belinta 60mg Tablet?
What is the most important thing I should know about Belinta 60mg Tablet?
What will happen if I stop taking Belinta 60mg Tablet?
Should I stop taking Belinta 60mg Tablet before having surgery or dental treatment?
How long does Belinta 60mg Tablet take to work?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 871-72.
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 351-52.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1359-60.